Spontaneous Cholemia in C57BL/6 Mice Predisposes to Liver Cancer in NASH.
作者信息
Gallage Suchira, Ali Adnan, Barragan Avila Jose Efren, Herebian Diran, Karimi Mohammad M, Irvine Elaine E, McHugh Domhnall, Schneider Anne T, Vucur Mihael, Keitel Verena, Gil Jesús, Withers Dominic J, Luedde Tom, Heikenwalder Mathias
机构信息
Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany.
出版信息
Cell Mol Gastroenterol Hepatol. 2022;13(3):875-878. doi: 10.1016/j.jcmgh.2021.11.012. Epub 2021 Dec 6.
Abstract
摘要
相似文献
1
Spontaneous Cholemia in C57BL/6 Mice Predisposes to Liver Cancer in NASH.
Cell Mol Gastroenterol Hepatol. 2022;13(3):875-878. doi: 10.1016/j.jcmgh.2021.11.012. Epub 2021 Dec 6.
2
A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer.
J Hepatol. 2016 Sep;65(3):579-88. doi: 10.1016/j.jhep.2016.05.005. Epub 2016 May 31.
3
Response to Spontaneous Cholemia in C57BL/6 Mice Predisposes to Liver Cancer in NASH.
Cell Mol Gastroenterol Hepatol. 2022;13(5):1590. doi: 10.1016/j.jcmgh.2022.01.012. Epub 2022 Feb 12.
4
Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells.
Stem Cell Res Ther. 2021 Jul 28;12(1):429. doi: 10.1186/s13287-021-02476-6.
5
Enterohepatic Shunt-Driven Cholemia Predisposes to Liver Cancer.
Gastroenterology. 2022 Dec;163(6):1658-1671.e16. doi: 10.1053/j.gastro.2022.08.033. Epub 2022 Aug 18.
6
Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
J Hepatol. 2021 Mar;74(3):511-521. doi: 10.1016/j.jhep.2020.09.033. Epub 2020 Oct 8.
7
Formononetin promotes fatty acid β-oxidation to treat non-alcoholic steatohepatitis through SIRT1/PGC-1α/PPARα pathway.
Phytomedicine. 2024 Feb;124:155285. doi: 10.1016/j.phymed.2023.155285. Epub 2023 Dec 16.
8
Development of a classification model for non-alcoholic steatohepatitis (NASH) using confocal Raman micro-spectroscopy.
J Biophotonics. 2017 Dec;10(12):1703-1713. doi: 10.1002/jbio.201600303. Epub 2017 Jun 21.
9
Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
Am J Physiol Gastrointest Liver Physiol. 2020 Jan 1;318(1):G174-G188. doi: 10.1152/ajpgi.00041.2019. Epub 2019 Oct 21.
10
Oxidative stress and Liver X Receptor agonist induce hepatocellular carcinoma in Non-alcoholic steatohepatitis model.
J Gastroenterol Hepatol. 2021 Mar;36(3):800-810. doi: 10.1111/jgh.15239. Epub 2020 Oct 5.
引用本文的文献
1
Elevated systemic total bile acids escalate susceptibility to alcohol-associated liver disease.
iScience. 2024 Sep 13;27(10):110940. doi: 10.1016/j.isci.2024.110940. eCollection 2024 Oct 18.
2
Prospective Application of Tannic Acid in Acetaminophen (APAP)-Induced Acute Liver Failure.
Int J Mol Sci. 2023 Dec 25;25(1):317. doi: 10.3390/ijms25010317.
3
Reply.
Cell Mol Gastroenterol Hepatol. 2022;13(5):1590-1591. doi: 10.1016/j.jcmgh.2022.01.013. Epub 2022 Feb 12.
4
Response to Spontaneous Cholemia in C57BL/6 Mice Predisposes to Liver Cancer in NASH.
Cell Mol Gastroenterol Hepatol. 2022;13(5):1590. doi: 10.1016/j.jcmgh.2022.01.012. Epub 2022 Feb 12.
本文引用的文献
1
The therapeutic landscape of hepatocellular carcinoma.
Med. 2021 May 14;2(5):505-552. doi: 10.1016/j.medj.2021.03.002. Epub 2021 Apr 27.
2
Liver Inflammation and Hepatobiliary Cancers.
Trends Cancer. 2021 Jul;7(7):606-623. doi: 10.1016/j.trecan.2021.01.012. Epub 2021 Mar 2.
3
From NASH to HCC: current concepts and future challenges.
Nat Rev Gastroenterol Hepatol. 2019 Jul;16(7):411-428. doi: 10.1038/s41575-019-0145-7.
4
Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments.
BMC Gastroenterol. 2018 Jul 11;18(1):112. doi: 10.1186/s12876-018-0842-7.
5
Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes.
Cancer Cell. 2014 Oct 13;26(4):549-64. doi: 10.1016/j.ccell.2014.09.003.
6
Bile acids activate YAP to promote liver carcinogenesis.
Cell Rep. 2013 Nov 27;5(4):1060-9. doi: 10.1016/j.celrep.2013.10.030. Epub 2013 Nov 21.
7
Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment.
Am J Physiol Gastrointest Liver Physiol. 2013 Oct 1;305(7):G483-95. doi: 10.1152/ajpgi.00079.2013. Epub 2013 Jul 25.
8
The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
Arch Dermatol. 2007 Jun;143(6):757-62. doi: 10.1001/archderm.143.6.757.
9
Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates.
Hepatology. 2004 Aug;40(2):467-74. doi: 10.1002/hep.20336.
10
Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet.
Am J Physiol Endocrinol Metab. 2002 Apr;282(4):E834-42. doi: 10.1152/ajpendo.00332.2001.
Zotero 插件